Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer Journal Article


Authors: Bowtell, D. D.; Böhm, S.; Ahmed, A. A.; Aspuria, P. J.; Bast, R. C. Jr; Beral, V.; Berek, J. S.; Birrer, M. J.; Blagden, S.; Bookman, M. A.; Brenton, J. D.; Chiappinelli, K. B.; Martins, F. C.; Coukos, G.; Drapkin, R.; Edmondson, R.; Fotopoulou, C.; Gabra, H.; Galon, J.; Gourley, C.; Heong, V.; Huntsman, D. G.; Iwanicki, M.; Karlan, B. Y.; Kaye, A.; Lengyel, E.; Levine, D. A.; Lu, K. H.; McNeish, I. A.; Menon, U.; Narod, S. A.; Nelson, B. H.; Nephew, K. P.; Pharoah, P.; Powell, D. J. Jr; Ramos, P.; Romero, I. L.; Scott, C. L.; Sood, A. K.; Stronach, E. A.; Balkwill, F. R.
Article Title: Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer
Abstract: High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015. © 2015 Macmillan Publishers Limited. All rights reserved.
Journal Title: Nature Reviews Cancer
Volume: 15
Issue: 11
ISSN: 1474-175X
Publisher: Nature Publishing Group  
Date Published: 2015-11-01
Start Page: 668
End Page: 679
Language: English
DOI: 10.1038/nrc4019
PROVIDER: scopus
PUBMED: 26493647
PMCID: PMC4892184
DOI/URL:
Notes: Export Date: 2 November 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Douglas A Levine
    380 Levine